NABEL ELIZABETH G

Director · LYEL, MRNA, MDT, ACCD

As of 2026-09-16, NABEL ELIZABETH G has 23 Form 4 transactions on record across 4 companies — 7 in the trailing 12 months.

Everything this person has disclosed to the SEC on Form 4 — across every company they file for — reconstructed from the public record. A filing history, not a tip sheet.

Reconstructed holdings

Direct: $3.1MIndirect: $0$3.1Mas of 2026-09-16
  • Direct $3.1M
  • Indirect $0
MDTdirect19,584 sh$1.8M
MRNAdirect8,371 sh$1.2M
LYELdirect9,250 sh$100K

Reconstructed from this person's own Form 4 filings — the total each filing reported owning afterward, priced at the close on the as-of date shown. A filed position can lag the real one.

Direct and indirect holdings (e.g. through a trust or fund) are tagged separately, as filed.

Trades by company

ACCD · 9 trades
2025-04-08: Disposition, 41,982 sh ($295K)2025-04-08: Disposition, 35,021 sh2025-04-08: Disposition, 12,489 sh2025-04-08: Disposition, 12,489 sh2025-04-08: Disposition, 35,021 sh2025-03-03: Award / grant, 12,489 sh ($0)2025-02-28: Option exercise, 2,178 sh ($0)2025-02-28: Option exercise, 2,178 sh2025-02-28: Option exercise, 2,178 sh
MRNA · 8 trades
2026-05-06: Award / grant, 8,371 sh ($0)2026-04-30: Option exercise, 16,233 sh ($0)2026-04-30: Option exercise, 16,233 sh2026-04-30: Option exercise, 16,233 sh2025-04-30: Award / grant, 16,233 sh ($0)2025-04-30: Option exercise, 979 sh ($0)2025-04-30: Option exercise, 979 sh2025-04-30: Option exercise, 979 sh
MDT · 4 trades
2026-04-28: Withheld for tax, 207 sh ($17K)2026-04-27: Award / grant, 2,111 sh ($0)2025-04-29: Withheld for tax, 216 sh ($18K)2025-04-28: Award / grant, 2,083 sh ($175K)
LYEL · 2 trades
2026-06-10: Award / grant, 9,250 sh ($0)2025-05-15: Award / grant, 130,000 sh ($0)

Filing ledger

DateCompanyActionShares @ priceValueOwnership ΔOwned afterFiling
23 award / exercise / gift records — not counted as purchases
DateCompanyActionSharesOwned afterFiling
2026-06-10LYELAward / grant9,2509,250Form 4
2026-05-06MRNAAward / grant8,3718,371Form 4
2026-04-30MRNAOption exercise16,2330Form 4
2026-04-30MRNAOption exercise16,23319,317Form 4
2026-04-30MRNAOption exercise16,23319,317Form 4
2026-04-28MDTWithheld for tax20719,584Form 4
2026-04-27MDTAward / grant2,11119,791Form 4
2025-05-15LYELAward / grant130,000130,000Form 4
2025-04-30MRNAAward / grant16,23316,233Form 4
2025-04-30MRNAOption exercise9790Form 4
2025-04-30MRNAOption exercise9793,084Form 4
2025-04-30MRNAOption exercise9793,084Form 4
2025-04-29MDTWithheld for tax21617,615Form 4
2025-04-28MDTAward / grant2,08317,831Form 4
2025-04-08ACCDDisposition41,9820Form 4
2025-04-08ACCDDisposition35,0210Form 4
2025-04-08ACCDDisposition12,4890Form 4
2025-04-08ACCDDisposition12,4890Form 4
2025-04-08ACCDDisposition35,0210Form 4
2025-03-03ACCDAward / grant12,48912,489Form 4
2025-02-28ACCDOption exercise2,17841,982Form 4
2025-02-28ACCDOption exercise2,1780Form 4
2025-02-28ACCDOption exercise2,1780Form 4

Source: SEC Form 4 filings. Each row links to its original filing.

Research tool, not investment advice — historical frequencies, not recommendations. A product of Marovel Technologies LLC. Full terms.